A novel therapeutic concept for the treatment of acute angioedema attacks in hereditary angioedema patients: multiple successful treatments even in severe swelling attacks with the bradykinin-B2 receptor antagonist Icatibant

Ítems similars

• Icatibant, a New Bradykinin-Receptor Antagonist, in Hereditary Angioedema
  per: Cicardi, M., et al.
  Publicat: (2010)
• 165 Early Versus Delayed Treatment of Swelling Attacks with Icatibant, a Bradykinin 2 Receptor Antagonist in Patients With Hereditary Angioedema due to C1-INH Deficiency
  per: Bork, Konrad, et al.
  Publicat: (2012)
• 164 Treatment of Acquired Angioedema with the Bradykinin Receptor Antagonist Icatibant
  per: Siani, Maria Concetta, et al.
  Publicat: (2012)
• Case report of treatment with Icatibant for recurrent throat swelling due to hereditary angioedema
  per: Chung, Arthur G, et al.
  Publicat: (2010)
• Hereditary angioedema attacks resolve faster and are shorter after early icatibant treatment.
  per: Marcus Maurer, et al.
  Publicat: (2013-01-01)